Efficacy and safety of erdafitinib in patients with high-grade and low-grade gliomas and prespecified fibroblast growth factor receptor alterations (FGFRALT) in the Ragnar trial Meeting Abstract
| Authors: | Reardon, D.; Welsh, L.; Shih, K.; Shimizu, T.; Goeminne, J. C.; Geoerger, B.; Baldini, C.; Massard, C.; Loriot, Y.; Pant, S.; Sait, S. F.; Sait, F.; Thomas, S.; Hammond, C.; Najmi, S.; Triantos, S.; Crow, L.; Sweiti, H.; Witt, O. |
| Abstract Title: | Efficacy and safety of erdafitinib in patients with high-grade and low-grade gliomas and prespecified fibroblast growth factor receptor alterations (FGFRALT) in the Ragnar trial |
| Meeting Title: | 28th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO) |
| Journal Title: | Neuro-Oncology |
| Volume: | 25 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2023 Nov 15-19 |
| Meeting Location: | Vancouver, Canada |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-11-01 |
| Start Page: | v91 |
| Language: | English |
| ACCESSION: | WOS:001115245400347 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/noad179.0346 |
| Notes: | Meeting Abstract: CTNI-64 -- Source: Wos |
